Panel Discussion: A Therapeutic Revolution Against Aging – Bridging the Gaps & Opportunities
Time: 4:50 pm
day: Day One
Details:
- Examining what we do and do not know about the aging process
- Exploring the targeting of aging as a disease vs. aging as a common factor for different conditions
- Analyzing the current R&D landscape for anti-aging therapeutics
- Discussing recent breakthroughs and the growing interest in this space – attracting funding/ partnerships, important learnings to date and perspectives on future directions
Speakers:
Lewis S. Gruber is the co-founder and CEO of SIWA Therapeutics, Inc. Prior to SIWA, he was interim CEO of a company developing a natural killer cell line product; he resigned to found SIWA. He also co-founded and was CEO of Arryx, Inc. (acquired by a publicly-held company). While CEO, Arryx received awards including World…Read more
Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501(c)(3) biomedical research charity that performs and funds laboratory research dedicated to combating the aging process. He is also VP of New Technology Discovery at AgeX Therapeutics, a biotechnology startup developing…Read more
Over 15 years’ experience in a fast-track career, from premier research institutions to co-founding biotech and venture capital firms. Co-founded 5 biotech companies in Europe and the US. Currently, He is a co-founder and CEO at Senolytic Therapeutics Inc., a pharmaceutical company that develops a novel class of medicines by targeting senescence cells. He is…Read more
Marco co-founded Rubedo Life Sciences, with the company’s mission aimed to increase healthspan by treating the causes of age-related diseases. The strategy is based on systemic therapies capable of safely targeting across the body specific cell types, such as senescent cells, stem cells or cancer cells. Marco also co-founded Wetware Concepts, YEBN and Turn Biotechnology.…Read more